Literature DB >> 21541749

Combining molecular dynamics and docking simulations of the cytidine deaminase from Mycobacterium tuberculosis H37Rv.

Luís Fernando Saraiva Macedo Timmers1, Rodrigo Gay Ducati, Zilpa Adriana Sánchez-Quitian, Luiz Augusto Basso, Diógenes Santiago Santos, Walter Filgueira de Azevedo.   

Abstract

Cytidine Deaminase (CD) is an evolutionarily conserved enzyme that participates in the pyrimidine salvage pathway recycling cytidine and deoxycytidine into uridine and deoxyuridine, respectively. Here, our goal is to apply computational techniques in the pursuit of potential inhibitors of Mycobacterium tuberculosis CD (MtCDA) enzyme activity. Molecular docking simulation was applied to find the possible hit compounds. Molecular dynamics simulations were also carried out to investigate the physically relevant motions involved in the protein-ligand recognition process, aiming at providing estimates for free energy of binding. The proposed approach was capable of identifying a potential inhibitor, which was experimentally confirmed by IC(50) evaluation. Our findings open up the possibility to extend this protocol to different databases in order to find new potential inhibitors for promising targets based on a rational drug design process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21541749     DOI: 10.1007/s00894-011-1045-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  22 in total

1.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

2.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

Authors:  Robert A Copeland
Journal:  Methods Biochem Anal       Date:  2005

3.  Biosynthesis and scavenging of pyrimidines by pathogenic mycobacteria.

Authors:  P R Wheeler
Journal:  J Gen Microbiol       Date:  1990-01

Review 4.  Pyrimidine biosynthesis.

Authors:  G E Shambaugh
Journal:  Am J Clin Nutr       Date:  1979-06       Impact factor: 7.045

5.  A new method for predicting binding affinity in computer-aided drug design.

Authors:  J Aqvist; C Medina; J E Samuelsson
Journal:  Protein Eng       Date:  1994-03

6.  Essential dynamics of proteins.

Authors:  A Amadei; A B Linssen; H J Berendsen
Journal:  Proteins       Date:  1993-12

7.  The 1.48 A resolution crystal structure of the homotetrameric cytidine deaminase from mouse.

Authors:  Aik-Hong Teh; Makoto Kimura; Masaki Yamamoto; Nobuo Tanaka; Isamu Yamaguchi; Takashi Kumasaka
Journal:  Biochemistry       Date:  2006-06-27       Impact factor: 3.162

Review 8.  The resumption of consumption -- a review on tuberculosis.

Authors:  Rodrigo Gay Ducati; Antonio Ruffino-Netto; Luiz Augusto Basso; Diógenes Santiago Santos
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-11       Impact factor: 2.743

9.  Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.

Authors:  Maryse Lemaire; Louise F Momparler; Noël J-M Raynal; Mark L Bernstein; Richard L Momparler
Journal:  Cancer Chemother Pharmacol       Date:  2008-04-09       Impact factor: 3.333

10.  DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Authors:  David S Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali
Journal:  Nucleic Acids Res       Date:  2007-11-29       Impact factor: 16.971

View more
  1 in total

1.  Fusing a carbohydrate-binding module into the Aspergillus usamii β-mannanase to improve its thermostability and cellulose-binding capacity by in silico design.

Authors:  Cun-Duo Tang; Jian-Fang Li; Xi-Huan Wei; Rou Min; Shu-Juan Gao; Jun-Qing Wang; Xin Yin; Min-Chen Wu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.